Nandini V. Katre - Concepedia

Concepedia

Author

Nandini V. Katre

University of California, San Francisco

Also Known As

N V Katre, N.V. Katre, Nandini Katre, Nandini V Katre, Nandini V. Katre

22

Publications

1.7K

Citations

18

H-Index

54

Concepts

All Affiliations

University of California, San Francisco University of Pennsylvania CEP America

NV

About

Nandini V. Katre is an author at University of California, San Francisco specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.2K
2	Biochemistry	9	9	678
3	Natural Sciences	8	8	537
4	Engineering	3	3	315
5	Allergy	1	1	134

Nandini V. Katre

×

18

Publications

1.7K

Citations

18

H-Index

	Year	Citations
Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers. M J Knauf, D P Bell, P Hirtzer, Journal of Biological Chemistry InflammationWater-soluble PolymersCytokineModified Ril-2Ril-2 Therapy	1988	271
The conjugation of proteins with polyethylene glycol and other polymers Nandini V. Katre Advanced Drug Delivery Reviews Protein ChemistryEngineeringBiochemistryProtein FoldingNatural Sciences	1993	262
Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Nandini V. Katre, M J Knauf, W Laird Proceedings of the National Academy of Sciences InflammationCytokineAnti-inflammatoryInterleukin 2Polymer-drug Conjugate	1987	245
Site-Directed Pegylation of Recombinant Interleukin-2 at its Glycosylation Site Robert J. Goodson, Nandini V. Katre Nature Biotechnology BiochemistryBioconjugationGlycobiologyGlycosylation SiteCarbohydrate-protein Interaction	1990	155
DepoFoam™ technology: a vehicle for controlled delivery of protein and peptide drugs Qiang Ye, John Asherman, Mark Stevenson, Journal of Controlled Release Controlled DeliveryMedicinePeptide TherapeuticPharmaceutical TechnologyDrug Delivery Systems	2000	151
Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol. Nandini V. Katre The Journal of Immunology ImmunologyChemical ModificationImmunotherapeuticsImmunotherapySynthetic Immunology	1990	134
Multivesicular Liposome (DepoFoam) Technology for the Sustained Delivery of Insulin-Like Growth Factor-I (IGF-I) Nandini V. Katre, John Asherman, Heather Schaefer, Journal of Pharmaceutical Sciences	1998	88
Attachment site(s) of retinal in bacteriorhodopsin. Nandini V. Katre, Paul K. Wolber, Walther Stoeckenius, Proceedings of the National Academy of Sciences Normal LinkagePhotobiologyMolecular BiologyChemical BiologyPhototropin	1981	79
Interaction of uncouplers with the mitochondrial membrane: Identification of the high affinity binding site Nandini V. Katre, David F. Wilson Archives of Biochemistry and Biophysics Proteinlipid InteractionBiochemistryMitochondrial FunctionProtein FoldingMitochondrial Membrane	1978	56
Schedule dependency of the antitumor activity and toxicity of polyethylene glycol-modified interleukin 2 in murine tumor models. Robert J. Zimmerman, Sharon L. Aukerman, Nandini V. Katre, PubMed Peg-il-2 TreatmentAntitumor ActivityChemoprevention StrategyImmunologyMetronomic Chemotherapy	1989	54

Page 1